Glucose Health (GLUC) versus The Competition Critical Analysis

Institutional & Insider Ownership

16.7% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 22.6% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Risk and Volatility

Glucose Health has a beta of 3.51, suggesting that its stock price is 251% more volatile than the S&P 500. Comparatively, Glucose Health’s competitors have a beta of 1.46, suggesting that their average stock price is 46% more volatile than the S&P 500.

Profitability

This table compares Glucose Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-41.21%	-261.73%	-7.59%

Earnings & Valuation

This table compares Glucose Health and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-6.67
Glucose Health Competitors	$317.57 million	-$49.81 million	16.24

Glucose Health’s competitors have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

About Glucose Health

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.